Repository logo
 
Publication

The who-when-why triangle of complementary and alternative medicine use among Portuguese IBD patients

2017-04Journal article Open access
Simple item page
dc.contributor.authorPortela, Francisco
dc.contributor.authorDias, Camila C.
dc.contributor.authorCaldeira, Paulo
dc.contributor.authorCravo, Marilia
dc.contributor.authorDeus, João
dc.contributor.authorGonçalves, Raquel
dc.contributor.authorLago, Paula
dc.contributor.authorMorna, Henrique
dc.contributor.authorPeixe, Paula
dc.contributor.authorRamos, Jaime
dc.contributor.authorSousa, Helena Tavares
dc.contributor.authorTavares, Lurdes
dc.contributor.authorVasconcelos, Helena
dc.contributor.authorMagro, Fernando
dc.contributor.authorMinistro, Paula
dc.date.accessioned2019-11-20T15:07:41Z
dc.date.available2019-11-20T15:07:41Z
dc.date.issued2017-04
dc.description.abstractBackground: The use of complementary and alternative medicines is increasing among chronic patients, particularly those afflicted with inflammatory bowel diseases. Aim: This study aimed to address the prevalence of complementary and alternative medicines use among Portuguese inflammatory bowel diseases' patients. Methods: Patients were invited to fill an anonymous questionnaire concerning the use of complementary and alternative medicines. Results: Thirty-one per cent of the patients reported having used complementary and alternative medicines in the past, whereas 12% were using them by the time the questionnaire was administered. Fifty-nine per cent of the users did not share this information with their physician, whereas 14% and 8% discontinued their medication and periodical examination, respectively. Steroids prescription (OR = 2.880) and a higher instruction level (OR = 3.669) were predictors of complementary and alternative medicines use in this cohort. Conclusions: Roughly a third of Portuguese IBD patients had used CAM. Steroid treatment and an academic degree are associated with CAM use. Given the potential side effects and interactions, patient information about the benefits and limitations of conventional and complementary treatments should be reinforced. (C) 2017 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
dc.description.sponsorshipGEDII (Portuguese IBD Study Group)
dc.description.versioninfo:eu-repo/semantics/publishedVersion
dc.identifier.doi10.1016/j.dld.2016.12.031
dc.identifier.issn1590-8658
dc.identifier.issn1878-3562
dc.identifier.urihttp://hdl.handle.net/10400.1/13167
dc.language.isoeng
dc.peerreviewedyes
dc.publisherElsevier Science Inc
dc.rights.urihttp://creativecommons.org/licenses/by-nd/4.0/
dc.subjectInflammatory-bowel-disease
dc.subjectNational-survey
dc.subjectHypnotherapy
dc.subjectTherapy
dc.subjectExperiences
dc.subjectMedication
dc.subjectManagement
dc.subjectAdherence
dc.subjectAttitudes
dc.subjectQuality
dc.titleThe who-when-why triangle of complementary and alternative medicine use among Portuguese IBD patients
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage396
oaire.citation.issue4
oaire.citation.startPage388
oaire.citation.titleDigestive and Liver Disease
oaire.citation.volume49
person.familyNameCaldeira
person.familyNameSousa
person.givenNamePaulo
person.givenNameHelena Tavares
person.identifier.ciencia-id1112-F0B2-19A3
person.identifier.ciencia-idCF1F-1163-1C4A
person.identifier.orcid0000-0002-2404-6295
person.identifier.orcid0000-0002-6626-205X
rcaap.rightsopenAccess
rcaap.typearticle
relation.isAuthorOfPublication3def3720-8982-4c46-801d-af640d508b59
relation.isAuthorOfPublication6b1d11dd-486f-4fb3-b41f-02e1cf6a5c2e
relation.isAuthorOfPublication.latestForDiscovery6b1d11dd-486f-4fb3-b41f-02e1cf6a5c2e

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
13167 linha 6 - DLD 2017.pdf
Size:
874.04 KB
Format:
Adobe Portable Document Format
Download

Collections

FCB2-Artigos (em revistas ou actas indexadas)
ULS2-Artigos (em revistas ou actas indexadas)
ULS_10.1-MED-Artigos